My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine.

    Erbel S, Reers C, Eckstein VW, Kleeff J, Büchler MW, Nawroth PP, Ritzel RA.

    Diabetes Care. 2008 Jun;31(6):1105-11. Epub 2008 Mar 3.PMID: 18316392 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells.

    Staiger K, Staiger H, Schweitzer MA, Metzinger E, Balletshofer B, Häring HU, Kellerer M.

    Diabetologia. 2005 Sep;48(9):1898-905. Epub 2005 Aug 3.PMID: 16078017 [PubMed - indexed for MEDLINE]Related articles

    3.

    Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.

    Liefvendahl E, Arnqvist HJ.

    Horm Metab Res. 2008 Jun;40(6):369-74. Epub 2008 Apr 7.PMID: 18393172 [PubMed - indexed for MEDLINE]Related articles

    4.

    Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.

    Päivärinta M, Tapanainen P, Veijola R.

    Pediatr Diabetes. 2008 Jun;9(3 Pt 2):83-90. Epub 2008 Jan 25.PMID: 18221431 [PubMed - indexed for MEDLINE]Related articles

    5.

    Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes.

    Le Roith D.

    Diabetes Metab Res Rev. 2007 Nov;23(8):593-9. Review.PMID: 17922476 [PubMed - indexed for MEDLINE]Related articles

    6.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom.

    Woehl A, Evans M, Tetlow AP, McEwan P.

    Cardiovasc Diabetol. 2008 Aug 11;7:24.PMID: 18694484 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.

    Kashiwagi H, McDunn JE, Simon PO Jr, Goedegebuure PS, Xu J, Jones L, Chang K, Johnston F, Trinkaus K, Hotchkiss RS, Mach RH, Hawkins WG.

    Mol Cancer. 2007 Jul 15;6:48.PMID: 17631687 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.

    Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.

    Exp Clin Endocrinol Diabetes. 2008 May;116(5):282-8.PMID: 18484560 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.

    Ashwell SG, Bradley C, Stephens JW, Witthaus E, Home PD.

    Diabetes Care. 2008 Jun;31(6):1112-7. Epub 2008 Mar 13.PMID: 18339977 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors.

    Fisher WE, Boros LG, Schirmer WJ.

    J Surg Res. 1996 Jun;63(1):310-3.PMID: 8661216 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.

    Monami M, Marchionni N, Mannucci E.

    Diabetes Res Clin Pract. 2008 Aug;81(2):184-9. Epub 2008 May 20.PMID: 18495286 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mitogenic potency of insulin glargine.

    Zełobowska K, Gumprecht J, Grzeszczak W.

    Endokrynol Pol. 2009 Jan-Feb;60(1):34-9. Review.PMID: 19224503 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Effects of insulin on proliferation and apoptosis of endometrial carcinoma cell]

    Zhao J, Xue FX, Hua SF, Zhang LZ.

    Zhonghua Fu Chan Ke Za Zhi. 2007 Oct;42(10):696-700. Chinese. PMID: 18241547 [PubMed - indexed for MEDLINE]Related articles

    15.

    Uroguanylin inhibits proliferation of pancreatic cancer cells.

    Kloeters O, Friess H, Giese N, Buechler MW, Cetin Y, Kulaksiz H.

    Scand J Gastroenterol. 2008;43(4):447-55.PMID: 18365910 [PubMed - indexed for MEDLINE]Related articles

    16.

    Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin.

    Wada T, Azegami M, Sugiyama M, Tsuneki H, Sasaoka T.

    Diabetes Res Clin Pract. 2008 Sep;81(3):269-77. Epub 2008 Jun 27.PMID: 18585815 [PubMed - indexed for MEDLINE]Related articles

    17.

    A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lispro.

    Johansson UB, Wredling R, Adamson U, Lins PE.

    Diabetes Metab. 2007 Dec;33(6):469-71. Epub 2007 Nov 26.PMID: 18032083 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes.

    Fakhoury W, Lockhart I, Kotchie RW, Aagren M, LeReun C.

    Pharmacology. 2008;82(2):156-63. Epub 2008 Aug 1.PMID: 18679040 [PubMed - indexed for MEDLINE]Related articles

    19.

    Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.

    Ibrahim YH, Byron SA, Cui X, Lee AV, Yee D.

    Mol Cancer Res. 2008 Sep;6(9):1491-8.PMID: 18819936 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.

    Harris S, Yale JF, Dempsey E, Gerstein H.

    Can Fam Physician. 2008 Apr;54(4):550-8.PMID: 18411384 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity